Top compounds associated with response to TNPO2


Feature Type Standardized
Nominal ANOVA
mRNA XMD13-2 GDSC1000 pan-cancer AAC 0.14 9e-06
mRNA PI-103 CTRPv2 pan-cancer AAC 0.16 9e-06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.14 1e-05
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC 0.13 1e-05
mRNA piperlongumine CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.14 2e-05
Download CSV